Tenofovir Versus Entecavir for Hepatocellular Carcinoma Prevention in an International Consortium of Chronic Hepatitis BYao‐Chun Hsu, Mindie H. Nguyen, Grace Lai‐Hung Wong et al.|The American Journal of Gastroenterology|2019Cited by 102
Real-World Effectiveness From the Asia Pacific Rim Liver Consortium for HBV Risk Score for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated With Oral Antiviral TherapyHwai‐I Yang, Mindie H. Nguyen, Ming‐Lun Yeh et al.|The Journal of Infectious Diseases|2019Cited by 101
Incidences and Determinants of Functional Cure During Entecavir or Tenofovir Disoproxil Fumarate for Chronic Hepatitis BYao‐Chun Hsu, Mindie H. Nguyen, Ming‐Lun Yeh et al.|The Journal of Infectious Diseases|2021Cited by 87
Transition rates to cirrhosis and liver cancer by age, gender, disease and treatment status in Asian chronic hepatitis B patientsMatt Liu, Jia‐Horng Kao, Tai‐Chung Tseng et al.|Hepatology International|2021Cited by 33
Effectiveness of entecavir vs tenofovir disoproxil fumarate for functional cure of chronic hepatitis B in an international cohortYao‐Chun Hsu, Mindie H. Nguyen, Dae Won Jun et al.|Hepatology International|2022Cited by 27